Clinical Trial Update: Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Pyridoxal 5'-Phosphate for tardive dyskinesia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• Pyridoxal 5'-phosphate (pyridoxal 5'-phosphate)

Snippet

Sponsor: Medicure | Conditions: Tardive Dyskinesia | Phase 2 | Status: TERMINATED